Editorial: Cutting edge in systemic lupus erythematosus

Immunol Res. 2017 Apr;65(2):429-431. doi: 10.1007/s12026-017-8910-6.

Authors

David P D'Cruz¹, Annegret Kuhn^{2

3}

Affiliations

¹ Louise Coote Lupus Unit, Guys and St Thomas' Hospitals, London, UK. David.DCruz@gstt.nhs.uk.
² Interdisciplinary Center for Clinical Trials (IZKS), University Medical Center Mainz, Mainz, Germany.
³ Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center (DKFZ), Heidelberg, Germany.

No abstract available

Publication types

Editorial
Introductory Journal Article
Portrait

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use*
Antiphospholipid Syndrome / complications
Antiphospholipid Syndrome / immunology*
B-Cell Activating Factor / immunology
Clinical Trials as Topic
Female
Humans
Hyperprolactinemia
Immune Tolerance
Immunotherapy / methods*
Infections / complications
Infections / immunology*
Lupus Erythematosus, Systemic / complications
Lupus Erythematosus, Systemic / drug therapy*
Lupus Erythematosus, Systemic / immunology*
Pregnancy
Pregnancy Complications*
T-Lymphocytes, Regulatory / immunology*
Vitamin D

Substances

Antibodies, Monoclonal, Humanized
B-Cell Activating Factor
Vitamin D
belimumab